Suven begins phase I trial of NCE SUVN-G3031 in US
SUVN-G3031 is for cognition in alzheimer’s disease under US-IND 123179
Suven Life Sciences informed that their NCE SUVN-3031 has!--more-->…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.